Clinical Trial Update: HER2 Vaccine for Locally Advanced Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a HER2-targeted vaccine for locally advanced HER2-positive breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HER2 vaccine

Snippet

Sponsor: Pravin T.P Kaumaya | Conditions: Breast Cancer, HER2-positive Breast Cancer | Phase 1 | Status: RECRUITING